Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Other Non-Current Liabilities (2016 - 2025)

Updated

Adaptimmune Therapeutics (ADAPY) posted Other Non-Current Liabilities of $4.49 million for Q2 2025, up 212.0% from $1.44 million a year earlier and up 2.8% from the prior quarter.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Other Non-Current Liabilities (2016 - 2025) Analysis & Trends

At the end of FY2024, Adaptimmune Therapeutics' Other Non-Current Liabilities came in at $4.27 million, up 204.3% from FY2023.

  • Annual Other Non-Current Liabilities has increased for five consecutive years, with a five-year compound annual growth rate of 48.2% (FY2019 to FY2024).
  • In prior years, Adaptimmune Therapeutics' Other Non-Current Liabilities was $1.4 million in FY2023 (+8.3%), $1.3 million in FY2022 (+92.6%), $673,000 in FY2021 (+4.5%) and $644,000 in FY2020 (+7.7%).
  • Quarterly Other Non-Current Liabilities has run from a low of $615,000 in Q3 2020 to a high of $4.94 million in Q3 2024 over five years.
  • On a year-over-year basis, Other Non-Current Liabilities has increased in each of the last 11 quarters, with growth averaging 128.3% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q3 2024, with growth of 264.2%; the weakest was Q3 2022, with a decline of 5.7%.
  • According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $4.37 million (Q1 2025), $4.27 million (Q4 2024) and $4.94 million (Q3 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 4.49 Mn
Mar 31, 2025 4.37 Mn
Dec 31, 2024 4.27 Mn
Sep 30, 2024 4.94 Mn
Jun 30, 2024 1.44 Mn
Mar 31, 2024 1.42 Mn
Dec 31, 2023 1.40 Mn
Sep 30, 2023 1.36 Mn
Jun 30, 2023 1.36 Mn
Mar 31, 2023 1.33 Mn
Dec 31, 2022 1.30 Mn
Sep 30, 2022 626,000.00
Jun 30, 2022 649,000.00
Mar 31, 2022 670,000.00
Dec 31, 2021 673,000.00
Sep 30, 2021 664,000.00
Jun 30, 2021 667,000.00
Mar 31, 2021 655,000.00
Dec 31, 2020 644,000.00
Sep 30, 2020 615,000.00
API Access

Adaptimmune Therapeutics PLC Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ADAPY&period=max&api_key=YOUR_API_KEY